Parents’ Wait For Covid Vaccine For Youngest Kids May End In June
Media outlets follow up on Moderna's FDA request for approval of its low-dose, two-shot covid vaccine for children younger than six years old. If given approval, Moderna's shots would be the first to go into the arms of the nation's youngest unvaxxed age group.
Chicago Tribune:
Feeling The Strain Of A Long Wait For A COVID-19 Vaccine For Young Children, Parents Welcome News Of Moderna’s Authorization Request: ‘It’s Like ... Society Has Moved On’
Moderna on Thursday submitted a request to the Food and Drug Administration for emergency authorization of its COVID-19 vaccine for children younger than 6, a welcome development for parents who have faced long waits to vaccinate their youngest children, particularly for those like Hutchinson, who have immunocompromised kids. Vaccine trials for young children have greater regulatory and ethical concerns and naturally come last after such measures have been tested and authorized for older people. But the long wait, beset with some delays, has stalled a return to normal for some families with babies and toddlers. In February, Pfizer had to delay its request for emergency authorization for the same age group in order to further test a third shot after its two-dose regimen was found to be not as effective in the youngest age bracket. (Buckley and Mijares Torres, 4/29)
NPR:
Moderna Seeks FDA Authorization For Vaccine For Very Young
The FDA will probably convene a committee of outside advisers to consider the request. The FDA is also awaiting data from Pfizer and BioNTech about the effectiveness of three doses of a low-dose version of their vaccine in children younger than age 5. Two doses proved ineffective, disappointing parents of young children eager to vaccinate their children. While officials had hoped to make a vaccine available for this age group by the end of April, the FDA is now expecting to consider it in June once all the data have been submitted, according to an official familiar with the issue who is not authorized to speak publicly. (Stein, 4/28)
The New York Times:
Vaccines For Young Children
Why hasn’t the F.D.A. approved a Covid-19 vaccine for children under 5? Government officials have given two conflicting answers in recent days — one that places responsibility on vaccine manufacturers, another that casts the lack of approval as a deliberate federal policy. It’s the latest instance of what has been a recurring problem during the pandemic. Public health officials have sent confusing messages about Covid policy. ... Either way, the situation has bred frustration among many Americans — such as parents of young children who are desperate to vaccinate their children. These parents listen to the public statements of government officials and the news coverage but fail to find comprehensible answers. (Leonhardt, 4/29)
